Patient Summary

Thyroid Profile Results (01/07/2026)

Clinical Interpretation

• A suppressed or low-normal TSH in an elderly patient increases risk of atrial fibrillation and osteoporosis
• For patients >60 years, many guidelines recommend targeting TSH in the mid-to-upper normal range (1-3 µIU/mL) rather than low-normal

Follow-Up Recommendations

1. Dose - Continue Current or Consider Minor Adjustment

• The current dose of 100 mcg is adequate - do NOT increase
• Since TSH is 0.783 (low-normal in a 62-year-old), you may consider reducing to 88 mcg if the patient has:
  • Osteopenia/osteoporosis
  • Atrial fibrillation or cardiac history
  • Symptoms of over-replacement (palpitations, tremor, insomnia, heat intolerance)
• If asymptomatic with good bone health and no cardiac issues, continuing 100 mcg with monitoring is also acceptable

2. Monitoring Schedule (per ATA guidelines)

• Next TSH check: in 4-6 months (if dose unchanged)
• After that, annual TSH monitoring once stable euthyroid state is confirmed
• If dose changed: recheck TSH no earlier than 6 weeks after the dose change

3. Medication Counseling - Reinforce

• Take Levothyroxine on an empty stomach, 30-60 minutes before breakfast
• Avoid within 4 hours of: iron, calcium, antacids, PPI, fiber supplements, coffee
• Bedtime administration is an equally effective alternative for patients with polypharmacy

4. Age-Specific Considerations (62-year-old woman)

• Bone health: Check DEXA scan if not done recently - chronic levothyroxine use (especially if ever over-replaced) increases fracture risk
• Cardiac: Check for palpitations, irregular pulse - atrial fibrillation risk with low-normal/suppressed TSH
• Drug interactions: Review concurrent medications - phenytoin, carbamazepine, rifampicin, PPIs, iron, calcium all affect levothyroxine levels

5. Labs to Order at Next Visit

• TSH (primary monitoring parameter)
• Serum calcium, Vitamin D (bone health in elderly hypothyroid woman)
• Lipid profile if not recent (hypothyroidism-associated dyslipidemia)
• Consider Anti-TPO antibodies if not previously done (to confirm etiology - Hashimoto's vs. other)

6. Symptoms to Ask About

• Over-replacement signs: palpitations, heat intolerance, sweating, weight loss, diarrhea, tremor
• Under-replacement signs: fatigue, constipation, cold intolerance, weight gain, puffy face

Summary Advice

Continue Levothyroxine 100 mcg. TSH is controlled at 0.783. In a 62-year-old female, watch for signs of over-replacement and consider targeting TSH 1-3 µIU/mL. Recheck TSH in 4-6 months. Assess bone health and cardiac rhythm.

ECG Interpretation

Technical Details

• Paper speed: 50 mm/s (double standard - complexes appear wider than normal, circled in blue)
• Calibration: 10 mm/mV
• Filter: 35 Hz

Measurements (from printed strip)

Rhythm & Rate

• Sinus Bradycardia - HR 52 bpm
• Regular rhythm, every QRS preceded by a P wave
• P wave morphology normal (upright in aVF, inverted in aVR)

Key Findings

• Clinically significant finding in a 50-year-old female on follow-up
• In context of hypothyroidism, sinus bradycardia is a classic feature and may indicate residual/undertreated hypothyroidism or medication effect

• RV5 + SV1 = 30.45 mm (Sokolow-Lyon criterion: >35 mm for definite LVH)
• Borderline - does not meet full criteria but warrants monitoring
• Clinical correlation with BP and echo needed

• T axis deviation (151°) is abnormal, likely responsible for the machine's "inferior/lateral ST-T abnormality" flag
• Correlate with limb leads (II, III, aVF) for ST-T changes in inferior territory

• T wave inversion/change in V1 is circled - can be normal variant in V1, but requires correlation with clinical symptoms

• "Cannot rule out septal infarct - age undetermined" - likely false positive due to R-wave progression pattern; correlate with history
• "Possible LVH" - borderline voltage
• "Abnormal ECG" - due to bradycardia + voltage + T-axis

Clinical Correlation (Important)

• Sinus bradycardia fits perfectly as a manifestation of hypothyroidism
• Bradycardia may improve with adequate thyroxine replacement
• Borderline LVH may also be related to myxedematous cardiac changes

Suggested Action

1. 12-lead full ECG if only rhythm strip available - need all limb leads for complete assessment
2. Echo - to assess LV wall thickness, function (rule out pericardial effusion in hypothyroid patient)
3. BP measurement - to evaluate hypertensive LVH
4. If symptomatic bradycardia (dizziness, syncope, pre-syncope) - monitor closely
5. Recheck thyroid function - bradycardia in hypothyroid patient suggests possible under-replacement
6. Troponin only if chest pain or ischemic symptoms (machine flag of "septal infarct" is likely a false positive here)

Summary: Sinus bradycardia (52 bpm) with borderline LVH voltage and T-axis deviation. In context of hypothyroidism, bradycardia is likely hypothyroid-related. No acute ischemic changes identified. Recommend echo and clinical correlation.